August 4, 2022
PAR-22-188 - NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
NOT-CA-22-118 - Notice of Correction to PAR-22-187, NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to correct the Application Types allowed for PAR-22-188, NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed).
The following section of PAR-22-188 has been corrected:
Part 1. Overview Information, Section II. Award Information
Currently reads:
Application Types Allowed
New
Renewal
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
Corrected to read (in bold italics):
Application Types Allowed
New
Resubmission
Renewal
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
All other aspects of PAR-22-188 remain unchanged.
Scientific/Research Contact(s)
Christine Siemon
National Cancer Institute (NCI)
Telephone: 240-276-6266
Email: siemonc@mail.nih.gov
Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov
Financial/Grants Management Contact(s)
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@mail.nih.gov